Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geschwind, D. H.
Right arrow Articles by Cummings, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geschwind, D. H.
Right arrow Articles by Cummings, J. L.
NEUROLOGY 1995;45:557-560
© 1995 American Academy of Neurology

Sneddon's Syndrome Is a Thrombotic Vasculopathy

Neuropathologic and Neuroradiologic Evidence Daniel H. Geschwind, MD, PhD, Michael FitzPatrick, MD, MS, Paul S. Mischel, MD and Jeffrey L. Cummings, MD

Article abstract-We report the first case of pathologic findings from brain biopsy in a patient with Sneddon's syndrome. The observations suggest that Sneddon's syndrome is not a vasculitis but is more comparable to the autoimmune vasculopathies such as the antiphospholipid antibody syndrome. Vascular thrombosis and emboli from cardiac sources are the likely causes of stroke in most cases. The success of warfarin in the treatment of antiphospholipid syndromes and the failure of immunosuppression and aspirin in the treatment of Sneddon's syndrome argue that warfarin anticoagulation may be the most appropriate intervention currently available.

NEUROLOGY 1995;45: 557-560




This article has been cited by other articles:


Home page
 Arch NeurolHome page
Y. Aladdin, M. Hamadeh, and K. Butcher
The Sneddon Syndrome
Arch Neurol, June 1, 2008; 65(6): 834 - 835.
[Full Text] [PDF]

Home page
 CephalalgiaHome page
G. Tietjen, M. Al-Qasmi, P Gunda, and N. Herial
Sneddon's Syndrome: Another Migraine-Stroke Association?
Cephalalgia, March 1, 2006; 26(3): 225 - 232.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
J. A. Gomez-Puerta, R. Cervera, L. M. Calvo, and J. Font
Dementia associated with antiphospholipid antibodies: reply
Rheumatology, February 1, 2006; 45(2): 242 - 243.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
J. C. Adair
Dementia associated with antiphospholipid antibodies
Rheumatology, February 1, 2006; 45(2): 241 - 242.
[Full Text] [PDF]

Home page
 NeurologyHome page
D. A. Hilton and D. Footitt
Neuropathological findings in Sneddon's syndrome
Neurology, April 8, 2003; 60(7): 1181 - 1182.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
S M Boesch, A L Plorer, A J Auer, W Poewe, F T Aichner, S R Felber, and N T Sepp
The natural course of Sneddon syndrome: clinical and magnetic resonance imaging findings in a prospective six year observation study
J. Neurol. Neurosurg. Psychiatry, April 1, 2003; 74(4): 542 - 544.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
A. Tourbah, J. C. Piette, M. T. Iba-Zizen, O. Lyon-Caen, P. Godeau, and C. Frances
The Natural Course of Cerebral Lesions in Sneddon Syndrome
Arch Neurol, January 1, 1997; 54(1): 53 - 60.
[Abstract] [PDF]